These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 90920)

  • 1. Extracorporeal immunoadsorption: initial experience in human systemic lupus erythematosus.
    Terman DS; Buffaloe G; Mattioli C; Cook G; Tillquist R; Sullivan M; Ayus JC
    Lancet; 1979 Oct; 2(8147):824-7. PubMed ID: 90920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of rapidly progressive glomerulonephritis by extracorporeal immunoadsorption, prednisolone and cyclophosphamide.
    Palmer A; Cairns T; Dische F; Gluck G; Gjorstrup P; Parsons V; Welsh K; Taube D
    Nephrol Dial Transplant; 1991; 6(8):536-42. PubMed ID: 1956551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of immunoadsorption on the removal of immunoglobulin G autoantibodies in crescentic glomerulonephritis.
    Esnault VL; Testa A; Jayne DR; Soulillou JP; Guenel J
    Nephron; 1993; 65(2):180-4. PubMed ID: 8247177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of plasma exchange and immunoadsorption in systemic lupus erythematosus and antiphospholipid syndrome: A systematic review.
    Kronbichler A; Brezina B; Quintana LF; Jayne DR
    Autoimmun Rev; 2016 Jan; 15(1):38-49. PubMed ID: 26318215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disease activity in the nephritis of systemic lupus erythematosus in relation to serum complement concentrations. DNA-binding capacity and precipitating anti-DNA antibody.
    Cameron JS; Lessof MH; Ogg CS; Williams BD; Williams DG
    Clin Exp Immunol; 1976 Sep; 25(3):418-27. PubMed ID: 1085678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged membranous lupus nephritis with change of anti-ssDNA antibody titer and repeated renal relapse.
    Yumura W; Suganuma S; Nitta K; Sano Y; Uchida K; Nihei H
    Clin Exp Nephrol; 2004 Dec; 8(4):363-8. PubMed ID: 15619038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunologic therapy for glomerulonephritis with combined immunoadsorption and IVIG therapy].
    Welcker M; Helmke K
    Immun Infekt; 1995 Aug; 23(4):140-1. PubMed ID: 7558119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The course of anticardiolipin antibody levels under immunoadsorption therapy.
    Hauser AC; Hauser L; Pabinger-Fasching I; Quehenberger P; Derfler K; Hörl WH
    Am J Kidney Dis; 2005 Sep; 46(3):446-54. PubMed ID: 16129206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoadsorption onto protein A induces remission in severe systemic lupus erythematosus.
    Braun N; Erley C; Klein R; Kötter I; Saal J; Risler T
    Nephrol Dial Transplant; 2000 Sep; 15(9):1367-72. PubMed ID: 10978392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoadsorption (IAS) for systemic lupus erythematosus.
    Stummvoll GH
    Lupus; 2011 Feb; 20(2):115-9. PubMed ID: 21303827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The estimation of circulating immune complexes, C3d, and anti-ds-DNA-antibody serum levels in the monitoring of therapeutic plasmapheresis in a patient with systemic lupus erythematosus. A case report.
    Krapf F; Manger B; Koch B; Kraulledat P; Kalden JR
    Clin Exp Rheumatol; 1985; 3(2):159-62. PubMed ID: 3874738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoadsorbent plasma perfusion in patients with systemic lupus erythematosus.
    Schneider M; Berning T; Waldendorf M; Glaser J; Gerlach U
    J Rheumatol; 1990 Jul; 17(7):900-7. PubMed ID: 2213756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of circulating immune complexes, C3 and C4 complement components and anti-DNA antibody in different classes of lupus nephritis.
    Klein MH; Thorner PS; Yoon SJ; Poucell S; Baumal R
    Int J Pediatr Nephrol; 1984 Jun; 5(2):75-82. PubMed ID: 6333404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Murine lupus nephritis. Effects of glucocorticoid on circulating and tissue-bound immunoreactants.
    Cavallo T; Graves K; Granholm NA
    Lab Invest; 1983 Oct; 49(4):476-81. PubMed ID: 6604840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoadsorption in Autoimmune Diseases Affecting the Kidney.
    Stummvoll G; Aringer M; Handisurya A; Derfler K
    Semin Nephrol; 2017 Sep; 37(5):478-487. PubMed ID: 28863794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic lupus erythematosus glomerulonephritis in children.
    Garin EH; Shulman ST; Donnelly WH; Richard GA
    Paediatrician; 1981; 10(5-6):351-67. PubMed ID: 6460214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different mode of circulating immune complexes and anti-ssDNA antibodies in sera of lepromatous leprosy and systemic lupus erythematosus.
    Furukawa F; Yoshida H; Sekita K; Ozaki M; Imamura S; Hamashima Y
    Lepr Rev; 1984 Sep; 55(3):291-9. PubMed ID: 6492990
    [No Abstract]   [Full Text] [Related]  

  • 18. Murine lupus nephritis: effects of cyclophosphamide on circulating and tissue bound immunoreactants.
    Cavallo T; Graves K; Granholm NA
    Clin Exp Immunol; 1984 Jan; 55(1):67-73. PubMed ID: 6607142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoadsorption in SLE: three different high affinity columns are adequately effective in removing autoantibodies and controlling disease activity.
    Biesenbach P; Schmaldienst S; Smolen JS; Hörl WH; Derfler K; Stummvoll GH
    Atheroscler Suppl; 2009 Dec; 10(5):114-21. PubMed ID: 20129388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alper CA, Rosen FS: Studies of the in vivo behavior of human C'3 in normal subjects and patients.
    Alper CA; Rosen FS
    J Clin Invest; 1967 Dec; 46(12):2021-34. PubMed ID: 6074005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.